| Year |
Citation |
Score |
| 2018 |
Verma D, Tasan R, Sperk G, Pape HC. Neuropeptide Y2 receptors in anteroventral BNST control remote fear memory depending on extinction training. Neurobiology of Learning and Memory. PMID 29408468 DOI: 10.1016/J.Nlm.2018.01.011 |
0.399 |
|
| 2016 |
Verma D, Hörmer B, Bellmann-Sickert K, Thieme V, Beck-Sickinger AG, Herzog H, Sperk G, Tasan RO. Pancreatic polypeptide and its central Y4 receptors are essential for cued fear extinction and permanent suppression of fear. British Journal of Pharmacology. 173: 1925-38. PMID 26844810 DOI: 10.1111/Bph.13456 |
0.394 |
|
| 2015 |
Tasan RO, Verma D, Wood J, Lach G, Hörmer B, de Lima TC, Herzog H, Sperk G. The role of Neuropeptide Y in fear conditioning and extinction. Neuropeptides. PMID 26444585 DOI: 10.1016/J.Npep.2015.09.007 |
0.5 |
|
| 2015 |
Wood J, Verma D, Lach G, Bonaventure P, Herzog H, Sperk G, Tasan RO. Structure and function of the amygdaloid NPY system: NPY Y2 receptors regulate excitatory and inhibitory synaptic transmission in the centromedial amygdala. Brain Structure & Function. PMID 26365505 DOI: 10.1007/S00429-015-1107-7 |
0.459 |
|
| 2015 |
Verma D, Wood J, Lach G, Mietzsch M, Weger S, Heilbronn R, Herzog H, Bonaventure P, Sperk G, Tasan RO. NPY Y2 receptors in the central amygdala reduce cued but not contextual fear. Neuropharmacology. 99: 665-674. PMID 26314208 DOI: 10.1016/J.Neuropharm.2015.08.038 |
0.501 |
|
| 2015 |
Verma D, Wood J, Lach G, Herzog H, Sperk G, Tasan R. Hunger Promotes Fear Extinction by Activation of an Amygdala Microcircuit. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26062787 DOI: 10.1038/Npp.2015.163 |
0.394 |
|
| 2013 |
Shi YC, Lau J, Lin Z, Zhang H, Zhai L, Sperk G, Heilbronn R, Mietzsch M, Weger S, Huang XF, Enriquez RF, Baldock PA, Zhang L, Sainsbury A, Herzog H, et al. Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN. Cell Metabolism. 17: 236-48. PMID 23395170 DOI: 10.1016/J.Cmet.2013.01.006 |
0.359 |
|
| 2013 |
Hörtnagl H, Tasan RO, Wieselthaler A, Kirchmair E, Sieghart W, Sperk G. Patterns of mRNA and protein expression for 12 GABAA receptor subunits in the mouse brain. Neuroscience. 236: 345-72. PMID 23337532 DOI: 10.1016/J.Neuroscience.2013.01.008 |
0.356 |
|
| 2012 |
Verma D, Tasan R, Herzog H, Sperk G. NPY controls fear conditioning and fear extinction by combined action on Y1 and Y2 receptors British Journal of Pharmacology. 166: 1461-1473. PMID 22289084 DOI: 10.1111/J.1476-5381.2012.01872.X |
0.486 |
|
| 2011 |
Pavlov I, Huusko N, Drexel M, Kirchmair E, Sperk G, Pitkänen A, Walker MC. Progressive loss of phasic, but not tonic, GABAA receptor-mediated inhibition in dentate granule cells in a model of post-traumatic epilepsy in rats. Neuroscience. 194: 208-19. PMID 21840377 DOI: 10.1016/J.Neuroscience.2011.07.074 |
0.384 |
|
| 2011 |
Drexel M, Preidt AP, Kirchmair E, Sperk G. Parvalbumin interneurons and calretinin fibers arising from the thalamic nucleus reuniens degenerate in the subiculum after kainic acid-induced seizures. Neuroscience. 189: 316-329. PMID 21616128 DOI: 10.1016/J.Neuroscience.2011.05.021 |
0.312 |
|
| 2011 |
Tasan RO, Bukovac A, Peterschmitt YN, Sartori SB, Landgraf R, Singewald N, Sperk G. Altered GABA transmission in a mouse model of increased trait anxiety. Neuroscience. 183: 71-80. PMID 21458543 DOI: 10.1016/J.Neuroscience.2011.03.051 |
0.449 |
|
| 2011 |
Zambello E, Zanetti L, Hédou GF, Angelici O, Arban R, Tasan RO, Sperk G, Caberlotto L. Neuropeptide Y-Y2 receptor knockout mice: influence of genetic background on anxiety-related behaviors. Neuroscience. 176: 420-430. PMID 21055451 DOI: 10.1016/J.Neuroscience.2010.10.075 |
0.417 |
|
| 2010 |
Mazzuferi M, Palma E, Martinello K, Maiolino F, Roseti C, Fucile S, Fabene PF, Schio F, Pellitteri M, Sperk G, Miledi R, Eusebi F, Simonato M. Enhancement of GABA(A)-current run-down in the hippocampus occurs at the first spontaneous seizure in a model of temporal lobe epilepsy. Proceedings of the National Academy of Sciences of the United States of America. 107: 3180-5. PMID 20133704 DOI: 10.1073/Pnas.0914710107 |
0.367 |
|
| 2009 |
Tasan RO, Lin S, Hetzenauer A, Singewald N, Herzog H, Sperk G. Increased Novelty-Induced Motor Activity And Reduced Depression-Like Behavior In Neuropeptide Y (Npy)–Y4 Receptor Knockout Mice Neuroscience. 158: 1717-1730. PMID 19121371 DOI: 10.1016/J.Neuroscience.2008.11.048 |
0.442 |
|
| 2005 |
Wultsch T, Painsipp E, Thoeringer CK, Herzog H, Sperk G, Holzer P. Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors. Neuroscience. 136: 1097-1107. PMID 16216428 DOI: 10.1016/J.Neuroscience.2005.08.038 |
0.353 |
|
| 2005 |
Nishimura T, Schwarzer C, Gasser E, Kato N, Vezzani A, Sperk G. Altered expression of GABA(A) and GABA(B) receptor subunit mRNAs in the hippocampus after kindling and electrically induced status epilepticus. Neuroscience. 134: 691-704. PMID 15951123 DOI: 10.1016/J.Neuroscience.2005.04.013 |
0.371 |
|
| 2005 |
Painsipp E, Wultsch T, Sperk G, Herzog H, Holzer P. B76 Differential Changes In Stress-Induced Hyperthermia, Depression-Like Behaviour And Defaecation By Npy-Y2 And -Y4 Receptor Gene Knockout Behavioural Pharmacology. 16. DOI: 10.1097/00008877-200509001-00281 |
0.366 |
|
| 2005 |
Wultsch T, Painsipp E, Peskar BA, Sperk G, Herzog H, Holzer P. B8 Selective Increase Of Dark-Phase Water Intake In Npy-Y2 And -Y4 Receptor Knockout Mice Behavioural Pharmacology. 16. DOI: 10.1097/00008877-200509001-00213 |
0.39 |
|
| 1995 |
Vezzani A, Schwarzer C, Williamson J, Lothman E, Rizzi M, Sperk G. Differential changes in somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in chronic models of temporal lobe epilepsy Pharmacological Research. 31: 294. DOI: 10.1016/1043-6618(95)87436-4 |
0.301 |
|
| Show low-probability matches. |